Literature DB >> 27075259

Spleen hypoplasia leads to abnormal stress hematopoiesis in mice with loss of Pbx homeoproteins in splenic mesenchyme.

Rediet Zewdu1, Maurizio Risolino1,2, Alexandru Barbulescu1, Pradeep Ramalingam3, Jason M Butler3, Licia Selleri1,2.   

Abstract

The spleen plays critical roles in immunity and also provides a permissive microenvironment for hematopoiesis. Previous studies have reported that the TALE-class homeodomain transcription factor Pbx1 is essential in hematopoietic stem and progenitor cells (HSPCs) for stem cell maintenance and progenitor expansion. However, the role of Pbx1 in the hematopoietic niche has not been investigated. Here we explored the effects that genetic perturbation of the splenic mesenchymal niche has on hematopoiesis upon loss of members of the Pbx family of homeoproteins. Splenic mesenchyme-specific inactivation of Pbx1 (SKO) on a Pbx2- or Pbx3-deficient genetic background (DKO) resulted in abnormal development of the spleen, which is dysmorphic and severely hypoplastic. This phenotype, in turn, affected the number of HSPCs in the fetal and adult spleen at steady state, as well as markedly impairing the kinetics of hematopoietic regeneration in adult mice after sub-lethal and lethal myelosuppressive irradiation. Spleens of mice with compound Pyx deficiency 8 days following sublethal irradiation displayed significant downregulation of multiple cytokine-encoding genes, including KitL/SCF, Cxcl12/SDF-1, IL-3, IL-4, GM-CSF/Csf2 IL-10, and Igf-1, compared with controls. KitL/SCF and Cxcl12/SDF-1 were recently shown to play key roles in the splenic niche in response to various haematopoietic stresses such as myeloablation, blood loss, or pregnancy. Our results demonstrate that, in addition to their intrinsic roles in HSPCs, non-cell autonomous functions of Pbx factors within the splenic niche contribute to the regulation of hematopoiesis, at least in part via the control of KitL/SCF and Cxcl12/SDF-1. Furthermore, our study establishes that abnormal spleen development and hypoplasia have deleterious effects on the efficiency of hematopoietic recovery after bone marrow injury.
© 2016 Anatomical Society.

Entities:  

Keywords:  Cxcl12/SDF-1; GM-CSF; Nkx2-5+  spleen niche KitL/SCF; Pbx transcription factors; extramedullary hematopoiesis; hematopoietic stem cells; spleen hypoplasia

Mesh:

Substances:

Year:  2016        PMID: 27075259      PMCID: PMC5341595          DOI: 10.1111/joa.12479

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  90 in total

1.  Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow.

Authors:  A J Potocnik; C Brakebusch; R Fässler
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

Review 2.  The journey of developing hematopoietic stem cells.

Authors:  Hanna K A Mikkola; Stuart H Orkin
Journal:  Development       Date:  2006-10       Impact factor: 6.868

3.  Fetal spleen stroma drives macrophage commitment.

Authors:  Julien Y Bertrand; Guillaume E Desanti; Richard Lo-Man; Claude Leclerc; Ana Cumano; Rachel Golub
Journal:  Development       Date:  2006-08-16       Impact factor: 6.868

Review 4.  Development and function of the mammalian spleen.

Authors:  Andrea Brendolan; Maria Manuela Rosado; Rita Carsetti; Licia Selleri; T Neil Dear
Journal:  Bioessays       Date:  2007-02       Impact factor: 4.345

5.  Hox and Pbx factors control retinoic acid synthesis during hindbrain segmentation.

Authors:  Antonio Vitobello; Elisabetta Ferretti; Xavier Lampe; Nathalie Vilain; Sebastien Ducret; Michela Ori; Jean-François Spetz; Licia Selleri; Filippo M Rijli
Journal:  Dev Cell       Date:  2011-04-19       Impact factor: 12.270

6.  Pbx1/Pbx2 govern axial skeletal development by controlling Polycomb and Hox in mesoderm and Pax1/Pax9 in sclerotome.

Authors:  Terence D Capellini; Rediet Zewdu; Giuseppina Di Giacomo; Stefania Asciutti; Jamie E Kugler; Anna Di Gregorio; Licia Selleri
Journal:  Dev Biol       Date:  2008-04-16       Impact factor: 3.582

7.  The dynamics of spleen morphogenesis.

Authors:  Sally F Burn; Marit J Boot; Carlo de Angelis; Roisin Doohan; Carlos G Arques; Miguel Torres; Robert E Hill
Journal:  Dev Biol       Date:  2008-03-28       Impact factor: 3.582

8.  Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors.

Authors:  Francesca Ficara; Laura Crisafulli; Chenwei Lin; Masayuki Iwasaki; Kevin S Smith; Luca Zammataro; Michael L Cleary
Journal:  J Cell Sci       Date:  2013-05-09       Impact factor: 5.285

9.  Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche.

Authors:  Ryohichi Sugimura; Xi C He; Aparna Venkatraman; Fumio Arai; Andrew Box; Craig Semerad; Jeffrey S Haug; Lai Peng; Xiao-Bo Zhong; Toshio Suda; Linheng Li
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

10.  Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice.

Authors:  John P Chute; Garrett G Muramoto; Alice B Salter; Sarah K Meadows; Dennis W Rickman; Benny Chen; Heather A Himburg; Nelson J Chao
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

View more
  3 in total

1.  Niche-induced extramedullary hematopoiesis in the spleen is regulated by the transcription factor Tlx1.

Authors:  Akihisa Oda; Toshiki Tezuka; Yuta Ueno; Shoko Hosoda; Yusuke Amemiya; Chihiro Notsu; Toru Kasahara; Chiharu Nishiyama; Ryo Goitsuka
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

2.  A long noncoding RNA cluster-based genomic locus maintains proper development and visual function.

Authors:  Fei Wang; Dalong Ren; Xiaolin Liang; Shengwei Ke; Bowen Zhang; Bing Hu; Xiaoyuan Song; Xiangting Wang
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

Review 3.  The regulation of PBXs and their emerging role in cancer.

Authors:  Ying Liu; Xiang Ao; Xuehao Zhou; Chengcheng Du; Shouxiang Kuang
Journal:  J Cell Mol Med       Date:  2022-01-23       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.